LCAR-AIO Cells
IIT2021065
Phase 1 mab terminated
Quick answer
LCAR-AIO Cells for Acute Lymphocytic Leukemia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Lymphocytic Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated